Related references
Note: Only part of the references are listed.Qualitative insights into the opioid prescribing practices of Australian GP
Pallavi Prathivadi et al.
FAMILY PRACTICE (2020)
Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018
Wai Chung Tse et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision
Nicholas Lintzeris et al.
INTERNAL MEDICINE JOURNAL (2019)
Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids
Amanda Roxburgh et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids
Suzanne Nielsen et al.
PAIN MEDICINE (2018)
Predictors of persistent prescription opioid analgesic use among people without cancer in Australia
Samanta Lalic et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria
Rebecca McDonald et al.
ADDICTION (2016)
Prescription opioid analgesics for pain management in Australia: 20years of dispensing
M. M. Islam et al.
INTERNAL MEDICINE JOURNAL (2016)
Share Paper
